These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31157502)

  • 61. Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis.
    Liu ZL; Liu PP; Bi XW; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
    Cancer Med; 2019 Mar; 8(3):874-881. PubMed ID: 30706675
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
    Mead GM; Sydes MR; Walewski J; Grigg A; Hatton CS; Pescosta N; Guarnaccia C; Lewis MS; McKendrick J; Stenning SP; Wright D;
    Ann Oncol; 2002 Aug; 13(8):1264-74. PubMed ID: 12181251
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improved outcome in adult B-cell acute lymphoblastic leukemia.
    Hoelzer D; Ludwig WD; Thiel E; Gassmann W; Löffler H; Fonatsch C; Rieder H; Heil G; Heinze B; Arnold R; Hossfeld D; Büchner T; Koch P; Freund M; Hiddemann W; Maschmeyer G; Heyll A; Aul C; Faak T; Kuse R; Ittel TH; Gramatzki M; Diedrich H; Kolbe K; Fuhr HG; Fischer K; Schadeck-Gressel C; Weiss A; Strohscheer I; Metzner B; Fabry U; Gökbuget N; Völkers B; Messerer D; Uberla K
    Blood; 1996 Jan; 87(2):495-508. PubMed ID: 8555471
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy.
    Kazembe P; Hesseling PB; Griffin BE; Lampert I; Wessels G
    Med Pediatr Oncol; 2003 Jan; 40(1):23-5. PubMed ID: 12426682
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative.
    Afify Z; Orjuela-Grimm M; Smith CM; Dalal M; Ford JB; Pillai P; Robles JM; Reddy S; McCormack S; Ehrhardt MJ; Ureda T; Alperstein W; Edington H; Miller TP; Rubinstein JD; Kavanaugh M; Bukowinski AJ; Friehling E; Rivers JM; Chisholm KM; Marks LJ; Mason CC
    Br J Haematol; 2023 Feb; 200(3):297-305. PubMed ID: 36454546
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
    Rigaud C; Auperin A; Jourdain A; Haouy S; Couec ML; Aladjidi N; Gandemer V; Lambliotte A; Plat G; Landman-Parker J; Michon J; Leblanc T; Patte C; Minard-Colin V
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27873. PubMed ID: 31207026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience.
    Muwakkit SA; Razzouk BI; Shabb NS; Hancock ML; Dabbous I; Firzli S; Abboud MR
    J Pediatr Hematol Oncol; 2004 Nov; 26(11):749-53. PubMed ID: 15543011
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes.
    Opie J; Antel K; Koller A; Novitzky N
    Ann Hematol; 2020 Mar; 99(3):571-578. PubMed ID: 31955214
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
    Cubells Riero J; Pardo García N; Turmo Martí J; Vela Ferrer E; Badía Torroella RM; González Rivero MA; Illa Sala J; Melo Valls M
    An Esp Pediatr; 1988 Sep; 29(3):203-7. PubMed ID: 3195869
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
    Fayad L; Thomas D; Romaguera J
    Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S57-62. PubMed ID: 18284717
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
    Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G
    Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
    Corazzelli G; Frigeri F; Russo F; Frairia C; Arcamone M; Esposito G; De Chiara A; Morelli E; Capobianco G; Becchimanzi C; Volzone F; Saggese M; Marcacci G; De Filippi R; Vitolo U; Pinto A
    Br J Haematol; 2012 Jan; 156(2):234-44. PubMed ID: 22098541
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endemic Burkitt Lymphoma: Long-term Outcome in 87 Patients Who Presented With Paraplegia in Cameroon.
    Hesseling PB; Mbah G; Kouya F; Kimbi C; Nfor P; Kaah J; Kuruvilla R; Best A; Wharin P
    Pediatr Hematol Oncol; 2015; 32(8):525-8. PubMed ID: 26606160
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital.
    Sissolak G; Seftel M; Uldrick TS; Esterhuizen TM; Mohamed N; Kotze D
    J Glob Oncol; 2017 Jun; 3(3):218-226. PubMed ID: 28717763
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate.
    Hesseling P; Molyneux E; Kamiza S; Israels T; Broadhead R
    Ann Trop Paediatr; 2009 Mar; 29(1):29-34. PubMed ID: 19222931
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation.
    Strüßmann T; Fritsch K; Baumgarten A; Fietz T; Engelhardt M; Mertelsmann R; Ihorst G; Duyster J; Finke J; Marks R
    Br J Haematol; 2017 Sep; 178(6):927-935. PubMed ID: 28643323
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.
    Atra A; Gerrard M; Hobson R; Imeson JD; Ashley S; Pinkerton CR
    Br J Cancer; 1998 Jun; 77(12):2281-5. PubMed ID: 9649146
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment results of modified BFM protocol in pediatric high-risk Burkitt lymphoma.
    Vural S; Genç DB; Kebudi R; Doğan Ö; Karaman S
    Turk J Pediatr; 2021; 63(4):639-647. PubMed ID: 34449146
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study.
    Xiao J; Du S; Dai G; Gao G; Yang D; Zhao H
    Sci Rep; 2017 May; 7(1):1905. PubMed ID: 28507339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.